Omnicell [OMCL] vs Teladoc Health [TDOC] Detailed Stock Comparison

Omnicell Inc.

NASDAQ
Loading...

Teladoc Health Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Omnicell Inc. wins in 12 metrics, Teladoc Health Inc. wins in 6 metrics, with 0 ties. Omnicell Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Omnicell Inc. Teladoc Health Inc. Better
P/E Ratio (TTM) 918.75 N/A N/A
Price-to-Book Ratio 1.34 0.74 Teladoc Health Inc.
Debt-to-Equity Ratio 16.59 75.06 Omnicell Inc.
PEG Ratio -8.01 -6.16 Teladoc Health Inc.
EV/EBITDA 36.82 38.86 Omnicell Inc.
Profit Margin (TTM) 0.17% -7.92% Omnicell Inc.
Operating Margin (TTM) 2.20% -4.20% Omnicell Inc.
EBITDA Margin (TTM) 2.20% N/A N/A
Return on Equity 0.17% -13.93% Omnicell Inc.
Return on Assets (TTM) 0.36% -3.20% Omnicell Inc.
Free Cash Flow (TTM) $69.37M $137.33M Teladoc Health Inc.
1-Year Return 29.33% 7.00% Omnicell Inc.
Price-to-Sales Ratio (TTM) 1.41 0.41 Teladoc Health Inc.
Enterprise Value $1.68B $1.28B Omnicell Inc.
EV/Revenue Ratio 1.42 0.51 Teladoc Health Inc.
Gross Profit Margin (TTM) 41.51% 69.32% Teladoc Health Inc.
Revenue per Share (TTM) $26 $14 Omnicell Inc.
Earnings per Share (Diluted) $0.04 $-34.20 Omnicell Inc.
Beta (Stock Volatility) 0.86 2.08 Omnicell Inc.
Short % of Float 6.68% 16.55% Omnicell Inc.

Omnicell Inc. vs Teladoc Health Inc. Stock Performance Analysis

Loading Price Chart...

OMCL
TDOC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Omnicell Inc.5.71%-4.67%-7.26%16.62%-7.58%-11.41%
Teladoc Health Inc.1.63%5.37%17.30%38.40%1.63%5.82%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Omnicell Inc.29.33%-47.23%-73.67%16.01%151.70%181.05%
Teladoc Health Inc.7.00%-70.52%-95.30%-42.92%-73.79%-73.79%

Performance & Financial Health Analysis: Omnicell Inc. vs Teladoc Health Inc.

MetricOMCLTDOC
Market Information
Market Cap i$1.65B$1.04B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i390,0304,716,750
90 Day Avg. Volume i505,7634,439,277
Last Close$39.99$7.46
52 Week Range$26.85 - $55.00$4.40 - $9.77
% from 52W High-27.29%-23.64%
All-Time High$187.29 (Nov 22, 2021)$308.00 (Feb 15, 2021)
% from All-Time High-78.65%-97.58%
Growth Metrics
Quarterly Revenue Growth0.02%0.00%
Quarterly Earnings GrowthN/A0.00%
Financial Health
Profit Margin (TTM) i0.00%-0.08%
Operating Margin (TTM) i0.02%-0.04%
Return on Equity (TTM) i0.00%-0.14%
Debt to Equity (MRQ) i16.5975.06
Cash & Liquidity
Book Value per Share (MRQ)$27.36$7.77
Cash per Share (MRQ)$4.33$4.38
Operating Cash Flow (TTM) i$127.30M$294.36M
Levered Free Cash Flow (TTM) i$94.53M$226.14M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Omnicell Inc. vs Teladoc Health Inc.

MetricOMCL (Apr 24, 2026)TDOC (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i918.75N/A
Forward P/E i17.60-6.16
PEG Ratio i-8.01-6.16
Price to Sales (TTM) i1.410.41
Price to Book (MRQ) i1.340.74
Market Capitalization
Market Capitalization i$1.65B$1.04B
Enterprise Value i$1.68B$1.28B
Enterprise Value Metrics
Enterprise to Revenue i1.420.51
Enterprise to EBITDA i36.8238.86
Risk & Other Metrics
Beta i0.862.08
Book Value per Share (MRQ) i$27.36$7.77

Financial Statements Comparison: Omnicell Inc. vs Teladoc Health Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricOMCL (2025)TDOC (2025)
Revenue/Sales i1.18B2.53B
Cost of Goods Sold i681.40M771.59M
COGS % of Revenue i57.5%30.5%
Gross Profit i503.44M1.76B
Gross Margin i42.5%69.5%
Research & Development i88.67M277.92M
Operating Income (EBIT) i5.16M-163.40M
Operating Margin i0.4%-6.5%
EBITDA i91.79M260.18M
EBITDA Margin i7.7%10.3%
Pre-Tax Income i11.33M-235.53M
Pre-Tax Income % of Revenue i1.0%-9.3%
Income Tax i9.27M-35.21M
Income Tax % of Revenue i0.8%-1.4%
Net Income (Profit) i2.05M-200.32M
Profit Margin i0.2%-7.9%

Balance Sheet & Liquidity Metrics

MetricOMCL (2025)TDOC (2025)
Cash & Equivalents i196.52M781.08M
Total Current Assets i680.07M1.12B
Total Current Assets % of Revenue i57.4%44.2%
Total Current Liabilities i476.61M404.74M
Total Current Liabilities % of Revenue i40.2%16.0%
Long-Term Debt i192.39M1.03B
Long-Term Debt % of Revenue i16.2%40.7%
Total Shareholders Equity i1.23B1.39B
Retained Earnings i384.94M-16.43B
Retained Earnings % of Revenue i32.5%-649.4%
Property, Plant & Equipment i128.44M42.03M

Cash Flow Statement Comparison

MetricOMCL (2025)TDOC (2025)
Operating Cash Flow i155.13M225.59M
Operating Cash Flow % of Revenue i13.1%8.9%
Capital Expenditures i-40.42MN/A
Free Cash Flow i69.37M137.33M
FCF Margin i5.9%5.4%
Debt Repayment i-175.00M-550.63M
Common Stock Repurchase i-77.60MN/A

Short Interest & Institutional Ownership Analysis

MetricOMCLTDOC
Shares Short i2.50M29.71M
Short Ratio i4.166.89
Short % of Float i6.68%16.55%
Shares Outstanding i45.03M178.32M
Float Shares i41.91M176.23M
% Held by Insiders i2.20%0.65%
% Held by Institutions i106.39%75.86%
% Held by Public i-8.59%23.49%

Dividend Analysis & Yield Comparison: Omnicell Inc. vs Teladoc Health Inc.

MetricOMCLTDOC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A